# Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation

> **NCT03926845** · NA · COMPLETED · sponsor: **Institute of Dermatology, Thailand** · enrollment: 200 (actual)

## Conditions studied

- Facial Hyperpigmentation

## Interventions

- **OTHER:** Isobutylamido-thiazolyl-resorcinol Cream 0.2%
- **OTHER:** Vehicle

## Key facts

- **NCT ID:** NCT03926845
- **Lead sponsor:** Institute of Dermatology, Thailand
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-29
- **Primary completion:** 2020-11-30
- **Final completion:** 2021-01-31
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2022-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03926845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03926845, "Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03926845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*